Cite
The clinical promise of immunotherapy in triple-negative breast cancer
MLA
Praveen Vikas, et al. “The Clinical Promise of Immunotherapy in Triple-Negative Breast Cancer.” Cancer Management and Research, vol. 10, Dec. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e61639ac818d809260da16fb64d95037&authtype=sso&custid=ns315887.
APA
Praveen Vikas, Nicholas Borcherding, & Weizhou Zhang. (2018). The clinical promise of immunotherapy in triple-negative breast cancer. Cancer Management and Research, 10.
Chicago
Praveen Vikas, Nicholas Borcherding, and Weizhou Zhang. 2018. “The Clinical Promise of Immunotherapy in Triple-Negative Breast Cancer.” Cancer Management and Research 10 (December). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e61639ac818d809260da16fb64d95037&authtype=sso&custid=ns315887.